Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer

Clinical trial NCT05096338 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05096338
Sponsor: Abramson Cancer Center at Penn Medicine
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Prostate Cancer Cardiotoxicity Drug-Related Side Effects and Adverse Reactions Cardiovascular Diseases

Start date: 2021-10-27
Primary completion: 2029-11-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.